PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSONS DISEASE IN THE UNITED STATES

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74815-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)74815-4/fulltext
Title : PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSONS DISEASE IN THE UNITED STATES
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74815-4&doi=10.1016/S1098-3015(10)74815-4
First page :
Section Title :
Open access? : No
Section Order : 741
Categories :
Tags :
Regions :
ViH Article Tags :